*NAFLD ranges from simple fatty infiltration, without evidence of inflammation (non-alcoholic fatty liver (NAFL)), to fat and inflammation (non-alcoholic steatohepatitis (NASH)) and cirrhosis, which can progress to end-stage liver disease (ESLD) or directly to HCC. It is not a rule that all subjects with MetS develop NAFLD, nor do all subjects with NAFLD develop NASH [19].” Yellow Highlight [Page 3](zotero://open-pdf/library/items/I3K2TRVH?page=3&annotation=G22JVVW5)* 

**[[NAFLD_20260215_083]] can range from simple fatty inflitration without inflammation (NAFLD), to fat and inflammation (NASH), to cirrhosis, and may even progress to end-stage liver disease (ESLD) or Hepatocellular Carcinoma (HCC).** 


Browning, J.D.; Szczepaniak, L.S.; Dobbins, R.; Nuremberg, P.; Horton, J.D.; Cohen, J.C.; Grundy, S.M.; Hobbs, H.H. Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity. Hepatology 2004, 40, 1387–1395. [CrossRef]